← Leaderboards
Vineet Bhandari
Yale University
$3,045,622
Attributed
$3,045,622
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $413.8K · FY2005–20$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,045,622 · 4
By mechanism
R01$2,037,649 · 1
K08$663,951 · 1
R56$342,500 · 1
M01$1,522 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Sherry George Mansour$1,035,280
- Rong Fan$22,943,481
- Jack A Elias$29,308,180
- Mario Strazzabosco$13,580,250
- Seyedtaghi Takyar$1,899,775
Others in their field
Top investigators on “Hyperoxia”
- Robert O'Conner · Alion Science And Technology Corp$14,945,723
- Michael A O'Reilly · University Of Rochester$13,647,244
- Bhagavatula Moorthy · Baylor College Of Medicine$12,854,027
- Y. S. Prakash · Mayo Clinic Rochester$10,635,131
- Parviz Minoo Minoo · Children'S Hospital Los Angeles$9,283,386
- Aron B. Fisher · University Of Pennsylvania$7,487,757
Research focus
HyperoxiaInflammationCell DeathFetalMediatingAlveolarLungPathogenesisProgramsResponseInjuryPhenotypeBaseAnimalsNeonateFibroblast Growth FactorHistologyNeonatalOxygenBirthLung Injury, AcuteAdultBlood VesselsDefined Contribution
Grant awards (12)
Cellular Senescence as a New Mechanism of Bronchopulmonary Dysplasia (BPD)$342,500
R56 · FY2020 · HL · contact PI
Role of Angiogenic Agents in Alveolar Maturation and Injury$388,408
R01 · FY2013 · HL · contact PI
Role of Angiogenic Agents in Alveolar Maturation and Injury$407,991
R01 · FY2012 · HL · contact PI
Role of Angiogenic Agents in Alveolar Maturation and Injury$413,750
R01 · FY2011 · HL · contact PI
Role of Angiogenic Agents in Alveolar Maturation and Injury$413,750
R01 · FY2010 · HL · contact PI
Role of Angiogenic Agents in Alveolar Maturation and Injury$413,750
R01 · FY2009 · HL · contact PI
Angiogenic Agents and Alveolar Injury$133,285
K08 · FY2007 · HL · contact PI
Angiogenic Agents and Alveolar Injury$133,035
K08 · FY2006 · HL · contact PI
Angiogenic Agents and Alveolar Injury$132,788
K08 · FY2005 · HL
SURFACTANT INSTILLATION AND NASAL VENTILATION$1,522
M01 · FY2005 · RR
Angiogenic Agents and Alveolar Injury$132,543
K08 · FY2004 · HL
Angiogenic Agents and Alveolar Injury$132,300
K08 · FY2003 · HL